Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
FASN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CAMK2B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARHGAP33 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RNF207 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC155060 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
ADAMTS13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC29A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PPM1F - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KIF5A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SH3RF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KIFC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WDR90 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRELID3A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
COL7A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SFTPD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MROH6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on